Wave-shaped ribs were detected at prenatal ultrasound in a 20(+1) week female fetus. At birth, skeletal radiographs showed marked hypomineralization and suggested hypophosphatasia. However, elevated blood calcium and alkaline phosphatase excluded hypophosphatasia and raised the possibility of Jansen metaphyseal dysplasia. Molecular analysis of the PTH/PTHrP receptor gene (PTH1R) showed heterozygosity for a previously undescribed transversion variant (c.1373T>A), which predicts p.Ile458Lys. In vitro evaluation of wild type and mutant PTH/PTHrP receptors supported the pathogenic role of the p.Ile458Lys substitution, and confirmed the diagnosis of Jansen metaphyseal dysplasia. This disorder may present prenatally with wavy ribs and in the newborn with hypomineralization, and may therefore be confused with hypophosphatasia. The mottled metaphyseal lesions typically associated with this disease appear only in childhood.
We report our findings in a case of pulmonary atresia with intact ventricular septum and ventriculocoronary artery fistula in which power Doppler was used to make the diagnosis.A 30-year-old primiparous woman with no significant medical history presented at the fetal echocardiography service of our prenatal diagnosis center at 21 + 2 weeks of gestation after a routine sonographic examination had demonstrated a slightly enlarged fetal left cardiac ventricle. Sonography was performed using a Siemens Elegra ultrasound machine (Siemens, Erlangen, Germany) with a 3,5C40H transabdominal transducer. This showed fetal biometry to be consistent with gestational age and the extracardiac fetal morphology was normal. Twodimensional imaging of the four-chamber view confirmed that the left ventricle was slightly enlarged. The left outflow tract and the aortic arch were normal. Color Doppler examination demonstrated normal blood flow to the ventricles in diastole and absence of tricuspid valve regurgitation.The right ventricle was slightly hypoplastic with a hypertrophic myocardium and reduced movement. The main pulmonary artery diameter was reduced, the pulmonary arteries were perfused by retrograde flow from the ductus arteriosus and no flow through the pulmonary valve was detected. Power Doppler identified the presence of an anomalous vessel on the external wall of the heart which was confirmed by color Doppler and which demonstrated turbulent flow from the apex along the external wall of the right ventricle (Figures 1 and 2). Pulsed Doppler examination of this vessel demonstrated the presence of bidirectional flow: antegrade flow with a peak velocity of 150 cm/s and retrograde flow with a peak velocity of 110 cm/s (Figure 3). A diagnosis of pulmonary atresia with intact ventricular septum and abnormal communication between the right ventricle and left coronary artery was made.Fetal karyotyping following amniocentesis was normal and excluded the presence of the 22q11.2 deletion. The patient was counseled about the possibility of surgical repair, but opted for termination of pregnancy. Pathological examination of the fetus confirmed tricuspid atresia with hypoplastic right ventricle and, in place of the anterior descending ramus of the left coronary artery, there was an abnormally large, thick-walled ramus communicating with the right ventricular cavity (Figure 4), representing a ventriculocoronary artery fistula.Coronary artery fistulae are rare congenital anomalies which have recently been diagnosed in the antenatal period 1 -7 . They can occur in isolation or be associated with other cardiac anomalies, particularly flow obstruction pathologies. The fistula winds around the heart in a tortuous way and drains into a cardiac chamber
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.